Report Details

Organisation of clinical trials - new study announcing that industry's sales prospects

What's the outlook for the supplying and arrangement of medical testing? Visiongain's new report gives you revenue predictions, helping you stay ahead. There you see financial prospects. You also explore R&D trends, technologies, clients' needs, and opportunities.

That study gives you revenue forecasts to 2023 at overall world market, submarket, and national level. See what's happening, then, for those pharmaceutical contracting services - outsourcing and off-shoring - finding how you can gain.

Read on to explore that industry and discover what its future market could be worth.

Forecasts from 2013-2023 and other information to help you stay ahead in knowledge

Besides sales forecasting there to 2023, our new work shows historical data, growth rates, and market shares. There you find original analysis. See research and development (R&D) needs too. You also get 51 tables, 59 charts, and two interviews with companies.

Our study shows you what the future holds for pharma contract research organisations (CROs) and contract manufacturers (CMOs) supporting clinical trials.

You also see outlooks for related companies, including specialists in logistical support. See, too, implications for drug developers and clinical trial sponsors.

Gains through understanding those developmental services - advantages for your work

Why miss information you need? Why struggle to find data? Instead let our analysis guide you through that outsourcing industry's present and future.

That knowledge could bring you quicker, easier decisions, and results. Also you gain understanding to benefit your authority on clinical testing of drugs.

So use our predictions to help expand your business and give you more influence. You get the forecasting leaders need. Avoid falling behind there - find where the money lies.

The following sections show what you get, then, in our new investigation.

Revenues for the world clinical trial supply and logistics market and its submarkets

What are the secrets of that industry's progress? Along with prediction of the overall world market for that service provision, our work shows you individual revenue forecasting of three submarkets to 2023, at world level, for clinical trials:
• Manufacturing - also with forecasts for packaging and for other production
• Logistics and distribution - also with forecasts for cold chain logistics and for other services
• Supply chain management.

That report gives you feel for what stimulates and restrains that industry and market. There you identify potential for those technologies and services. See, then, how you can benefit.

You also find geographical revenue predictions.

National markets - what outlooks for service demand and provision?

Our analyses show you individual revenue forecasts to 2023 for 11 national markets:
• United States (US)
• Japan
• EU leaders - Germany, France, the UK, Italy, and Spain (EU5)
• BRIC countries - Brazil, Russia, India, and China.

For pharma service providers and clients, many opportunities exist in developed and developing countries. Progress worldwide will influence that market for outsourced services. See there how you and your organisation can benefit.

You find prospects. Our work explains, also exploring issues.

Developments, challenges, and opportunities affecting CROs, CMOs and other companies

The report explains forces affecting that industry and market from 2013, including these:
• Globalisation - access to new markets and patients
• Regulatory standards for clinical trial supply, inc. good manufacturing practice (GMP) and good distribution practice (GDP)
• Import regulations
• Supply chain security and other technology for developing and testing medicines
• Biological drugs (biologics) and other complex pharmaceuticals.

And also for these:
• Forecasting and modelling to maintain supply
• IT systems for clinical trial planning: IVRS and IWRS
• Participation in trials at home
• Adaptive clinical trials
• Management of multiple supplier networks.

There you explore political, economic, social, and technological questions, assessing outlooks for business. You also gain regulatory insights.

See there what the future holds.

Companies leading that industry and its overall 2017 value

What's possible for that industry? Our report predicts the world market for that clinical trial support will reach $14.3bn in 2017, expanding to 2023.

That work also shows you what technologies and organisations hold greatest potential. In particular, you explore activities of these companies:
• Catalent Pharma Solutions
• Patheon
• Almac Group
• Parexel International
• Fisher Clinical Services (FCS).

Our study also covers these firms, among others:
• World Courier
• DHL
• TNT Express
• FedEx
• Movianto.

You find 115 organisations covered. You also read interviews with two leaders in the industry. Discover, then, what participants do, say, and think, helping you stay ahead.

Analysis found nowhere else - discover the future of that pharma outsourcing

Through knowledge such as this, our new report helps you:
• Revenues to 2023 at world level for supporting clinical trials, with forecasts for 3 submarkets - assess prospects for investments, marketing, and revenues
• Forecasts to 2023 for 11 national markets in the Americas, Europe, and Asia -investigate developed and developing countries for potential sales
• Outlooks for established and rising service providers - assess results, portfolios, capabilities, clients, and prospects.

Clinical Trial Supply and Logistics: World Market Outlook 2013-2023 provides independent analysis. There you get competitive intelligence found only in our work, finding where money lies. Explore progress and possibilities.

See there how you could benefit your research, analysis, and decisions. Also find how you can save time and get recognition for insight. Try that study.

Table Of Contents

1. Executive Summary

1.1 Clinical Trial Supply and Logistics: World Market Overview 2013
1.2 Report Contents
1.2.1 Benefits of this Report
1.3 Study Methods
1.3.1 Who is this Report for?
1.3.2 Defining the Clinical Trial Supply and Logistics Market
1.4 An Introduction to the Clinical Trial Supply and Logistics Market
1.4.1 Clinical Trials are Becoming Increasingly Complex
1.4.1.1 Clinical Trial Globalisation: Access to New Markets and New Patients
1.4.2 Outsourcing Clinical Trial Supply and Logistics
1.4.2.1 What Services Are Most Commonly Outsourced?
1.4.3 Which Companies Participate in the Clinical Trial Supply and Logistics Market?
1.4.4 Clinical Trial Supply and Logistics: Trends and Future Outlook

2. Clinical Trial Supply and Logistics: World Market Outlook and Forecast 2013-2023

2.1 The World Clinical Trial Supply and Logistics Market 2012
2.1.1 Which Were the Leading Market Sectors in 2012?
2.2 The World Clinical Trial Supply and Logistics Market Forecast 2013-2023
2.2.1 What Will Drive Market Growth in this Decade?
2.2.2 Clinical Trial Supply and Logistics: Market Restraints 2013-2023
2.3 Clinical Trial Manufacturing Submarket 2013-2023
2.3.1 Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2013-2023
2.3.2 Complex Manufacturing and Packaging to Drive Growth 2013-2023
2.3.3 Clinical Trial Packaging Submarket Forecast 2013-2023
2.4 Clinical Trial Logistics and Distribution Submarket 2013-2023
2.4.1 Clinical Trial Logistics and Distribution Submarket Forecast 2013-2023
2.4.2 Submarket Drivers and Restraints 2013-2023
2.4.3 Clinical Trial Cold Chain Distribution Submarket Forecast 2013-2023
2.5 Clinical Trial Supply Chain Management Submarket 2013-2023
2.5.1 Clinical Trial Supply Chain Management Submarket Forecast 2013-2023
2.5.2 Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2013-2023

3. Leading National Markets for Clinical Trial Supply and Logistics 2013-2023

3.1 Defining National Submarkets for Clinical Trial Supply and Logistics
3.2 Leading National Submarkets for Clinical Trial Supply and Logistics 2012
3.2.1 How Will These Leading Submarkets Grow 2013-2023?
3.3 Clinical Trial Supply and Logistics in the US 2013-2023
3.3.1 How Will Demand for Clinical Trial Logistics Grow in the US to 2023?
3.4 Western Europe
3.4.1 Western Europe: Clinical Trial Supply and Logistics Submarket Forecast 2013-2023
3.4.2 The EU5: National Submarket Forecasts 2013-2023
3.5 Japan: A New and Growing Market for Outsourced Logistics
3.5.1 Japanese Clinical Trial Supply and Logistics Submarket Forecast 2013-2023
3.6 Clinical Trial Supply in Emerging Markets
3.7 The Latin American Clinical Trial Supply and Logistics Market 2013-2023
3.7.1 Challenging Distribution Conditions
3.7.2 Brazilian Clinical Trial Supply and Logistics Submarket Forecast 2013-2023
3.8 Russia and Central and Eastern Europe (CEE)
3.8.1 Outsourcing Will Grow Strongly in Russia
3.8.2 Russian Clinical Trial Supply and Logistics Submarket Forecast 2013-2023
3.9 India: An Emerging Destination for Outsourced Clinical Trials
3.9.1 New Clinical Trial Rules Restrain Growth in 2013
3.9.2 Indian Clinical Trial Supply and Logistics Submarket Forecast 2013-2023
3.10 Clinical Trial Supply and Logistics in China 2013-2023
3.10.1 Foreign Investment in Chinese Clinical Trial Logistics
3.10.2 Strong Growth for Clinical Trial Supply and Logistics in China 2013-2023

4. Clinical Trial Supply and Logistics: Regulatory Outlook 2013-2023

4.1 How do Regulatory Standards Affect Clinical Trial Supply?
4.1.1 Good Practices (GxP) in Clinical Trial Distribution
4.1.1.1 Good Manufacturing Practice (GMP)
4.1.1.2 Good Distribution Practice (GDP)
4.1.2 Import Regulations Complicate International Manufacturing and Trials
4.2 Clinical Trial Supply Regulations in the US 2013
4.2.1 Importing Drugs into the US: A Reinterpretation of the Rules
4.3 Clinical Trial Regulations in the EU 2013
4.3.1 Manufacturing Requirements for Clinical Trial Materials in the EU
4.3.2 The European Commission Releases New GDP Guidelines 2013
4.4 GMP and Importation Regulations for Pharmaceuticals in Japan 2013
4.5 Clinical Trial Supply Chain Regulations in Emerging Markets
4.5.1 China: Tougher Regulations for Pharmaceutical Companies and Service Providers
4.5.1.1 Improving Supply Chain Security in China 2013
4.5.2 India: Drug Manufacturing and Imports for Clinical Trials
4.5.2.1 The CDSCO Drafts New GDP Guidelines 2013
4.5.3 Brazil: Slow Regulatory Approval for Clinical Trials
4.5.4 Recent Updates to Pharmaceutical Regulation in Russia

5. Clinical Trial Supply and Logistics: Industry Trends 2013-2023

5.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2013
5.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats 2013-2023
5.3 Clinical Trial Supply and Logistics Market: STEP Analysis 2013-2023
5.3.1 Social Factors
5.3.2 How Will Novel Technologies Affect the Market to 2023?
5.3.3 Economic Pressures: Demands for Lower Cost Trials and Logistics
5.3.4 Political Issues
5.4 Securing the Clinical Trial Supply Chain 2013-2023
5.4.1 How Will Technology Improve Supply Chain Security?
5.5 How Will Clinical Trial Globalisation Impact Supply and Logistics?
5.6 Trends in Clinical Trial Manufacturing 2013-2023
5.6.1 The Challenge of Comparator Sourcing for Clinical Trials
5.6.1.1 Comparators Are a Source of Risk for Supply Chain Security
5.6.1.2 Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research
5.6.2 Trends in Packaging for Clinical Trials 2013-2023
5.7 Clinical Trial Supply Chain Management Trends to 2023
5.7.1 Forecasting and Modelling to Ensure Sufficient Supply
5.7.2 IT Systems Improve Clinical Trial Planning: IVRS and IWRS
5.7.3 Home-Based Trial Participation: Opportunities and Challenges for Logistics
5.7.4 How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?
5.8 Outsourcing Clinical Trial Supply and Logistics
5.8.1 Managing Multiple Supplier Networks

6. The Rise of Cold Chain Logistics in Clinical Trials 2013-2023

6.1 An Introduction to Cold Chain Supply and Distribution
6.1.1 The Importance of Cold Chain for Clinical Trials
6.1.2 Maintaining the Cold Chain
6.2 The Regulatory Outlook for Cold Chain Logistics
6.2.1 International Air Transport Regulations and Guidance: The Temperature Sensitive Label
6.3 Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2013-2023
6.3.1 Biologic Drug Development Will Drive Demand
6.3.1.1 Emerging Trends in Biological Drug Development
6.3.2 Pharma Cold Chain Logistics in Emerging Markets
6.4 The Role of Technology in Clinical Cold Chain Logistics
6.4.1 Active and Passive Temperature Control
6.4.2 There Are Many Ways to Maintain Temperature in the Cold Chain
6.4.2.1 Developments in Phase Change Materials
6.4.2.2 The Benefits of Liquid Nitrogen for Sample Transportation
6.4.3 Advances in RFID for Temperature Monitoring
6.4.3.1 Will Uptake for RFID Grow Among Biopharma Companies to 2023?
6.4.4 Future Technologies for Cold Chain Supply Management
6.4.4.1 Demand for Reusable Cold Chain Packaging

7. Clinical Trial Supply and Logistics Market: Leading Players 2013

7.1 Third Party Logistics Providers: Leading Clinical Distributors 2013
7.1.1 World Courier: A Pharmaceutical Supply Specialist
7.1.1.1 Distribution Services for Pharma, CROs and Central Laboratories
7.1.1.2 World Courier Is the Clinical Trial Distribution Market Leader
7.1.1.3 World Courier Opens New Service Depots in Europe and Latin America 2012
7.1.2 DHL: A Global Leader in Supply Chain Logistics
7.1.2.1 Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain
7.1.2.2 DHL Adds New Services for Healthcare and Clinical Trial Clients 2013
7.1.3 Marken
7.1.3.1 What Services Does Marken Offer Clinical Trial Sponsors?
7.1.3.2 Marken: Challenging Market Conditions 2008-2012
7.1.3.3 Marken Continues to Expand Worldwide
7.1.3.4 Expertise in Biological Sample Management
7.1.4 Other Leading and Emerging Players in the Market 2013
7.1.4.1 TNT Express
7.1.4.2 FedEx
7.1.4.3 Movianto Is a European Healthcare Specialist
7.2 Clinical Trial Manufacturing: Submarket Leaders 2013
7.2.1 Catalent Pharma Solutions
7.2.1.1 Clinical Trial Manufacturing and Supply Services
7.2.1.2 Strong Growth for Clinical Manufacturing Revenue, 2010-2013
7.2.1.3 Catalent Increases its Focus on Clinical Trial Manufacturing
7.2.2 Patheon
7.2.2.1 Patheon Is a Leader in Pharmaceutical Development Services
7.2.2.2 Patheon Completed 370 Clinical Projects in FY 2012
7.2.3 Almac Group: Manufacturing, Packaging and Logistics Services
7.2.3.1 Clinical Trial Supply and Management Solutions
7.2.3.2 Almac Opens New Facilities to Expand its Clinical Trial Expertise
7.3 The Role of CROs in the Clinical Trial Supply and Logistics Market
7.3.1 Parexel International
7.3.1.1 Parexel's Clinical Trial Supply and Logistics Services
7.3.1.2 Parexel Expands Worldwide 2012-2013
7.4 Other Leading Companies in the Clinical Trial Supply and Logistics Market 2013
7.4.1 Fisher Clinical Services (FCS)
7.4.1.1 FCS Offers Manufacturing, Packaging, Storage and Distribution Services
7.4.1.2 Fisher BioServices: Clinical Logistics for the Cell Therapy Industry
7.4.2 Packaging Coordinators Inc. (PCI)

8. Research Interviews 2013

8.1 Alex Guillen, CEO, Escort Cold Chain Solutions
8.1.1 Escort Cold Chain Solutions (ECCS)
8.1.2 Uptake of RFID for Pharmaceutical Cold Chain
8.1.3 RFID Beyond Temperature Monitoring
8.1.4 Emerging Technologies for Cold Chain Monitoring
8.1.5 Emerging Packaging Technologies
8.2 Onno Boots, Managing Director, Asia Pacific, MNX
8.2.1 MNX
8.2.1.1 MNX Is Expanding in Asia
8.2.2 Challenges in Clinical Trial Logistics
8.2.3 The Appeal of the Clinical Trial Logistics Market
8.2.4 Challenges in Asian Logistics
8.2.5 Future Expectations for the Clinical Trial Logistics Market
8.2.6 Demand for Cold Chain Services
8.2.7 The Cost of Clinical Trial Sample Logistics
8.2.8 New Technologies for Clinical Trial Logistics
8.2.9 MNX: A New Logistics Model for Clinical Research

9. Conclusions of Our Study

9.1 The Clinical Trial Supply and Logistics Market 2012-2013
9.2 Outlook for the Market 2013-2023
9.3 Growing Demand for Clinical Logistics in Emerging Markets
9.4 Technology and Innovation to Drive Outsourcing

List of Tables

Table 1.1 Currency Exchange Rates
Table 1.2 Clinical Trials Registered by Country/Region, 2013
Table 2.1 RandD Outsourcing Market: Revenue ($bn) and Market Share (%) by Sector, 2012
Table 2.2 Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Sector, 2012
Table 2.3 Clinical Trial Supply and Logistics Market: Overall Market and Revenue Forecasts by Sector ($bn), 2012-2023
Table 2.4 Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2012-2023
Table 2.5 Clinical Trial Manufacturing Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2012
Table 2.6 Clinical Trial Manufacturing Submarket: Overall Submarket and Revenue Forecasts by Sector ($bn), 2012-2023
Table 2.7 Clinical Trial Packaging Submarket Forecast ($bn), 2012-2023
Table 2.8 Clinical Trial Logistics and Distribution Submarket: Revenue ($bn) and Submarket Share (%) by Sector, 2012
Table 2.9 Clinical Trial Logistics and Distribution Submarket: Overall Submarket and Revenue Forecasts by Sector ($bn), 2012-2023
Table 2.10 Clinical Trial Cold Chain Logistics Submarket Forecast ($bn), 2012-2023
Table 2.11 Clinical Trial Supply Chain Management Submarket Forecast ($bn), 2012-2023
Table 3.1 Clinical Trial Supply and Logistics Market: Revenues ($bn) and Market Shares (%) by Country/Region, 2012
Table 3.2 Clinical Trial Supply and Logistics Market: Regional and National Submarket Revenue Forecasts ($bn), 2013-2023
Table 3.3 Clinical Trial Supply and Logistics Market: Regional and National Submarket Shares (%), 2012-2023
Table 3.4 US Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 3.5 Western European Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 3.6 Western European Clinical Trial Supply and Logistics Submarket: Revenues ($bn) and Market Shares (%) by Country, 2012
Table 3.7 Western European Clinical Trial Supply and Logistics Submarket: National Submarket Forecasts ($bn), 2012-2023
Table 3.8 Japanese Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 3.9 Selected Clinical Trial Logistics Investments in Latin America, 2012
Table 3.10 Brazilian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 3.11 Russian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 3.12 Indian Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 3.13 Selected Clinical Trial Logistics Investments in China, 2011-2013
Table 3.14 Chinese Clinical Trial Supply and Logistics: Submarket Forecast ($bn), 2012-2023
Table 4.1 ICH Guidelines Manufacturing Guidelines, 2000-2013
Table 5.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses, 2013
Table 5.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats, 2013-2023
Table 5.3 Clinical Trial Supply and Logistics Market: STEP Analysis, 2013-2023
Table 5.4 Commonwealth of Independent States: Registered Clinical Trials, 2013
Table 5.5 Comparative Costs of Orphan and Non-Orphan Clinical Trials, 2013
Table 5.6 TransCelerate BioPharma Member Companies, 2013
Table 5.7 The Benefits of Advanced Forecasting Tools for Clinical Trial Logistics
Table 5.8 Selected Clinical Trial Supply Forecasting Tools Available, 2013
Table 5.9 Selected IVRS/IWRS Tools Available for Clinical Trials, 2013
Table 5.10 Home-Based Clinical Trial Distribution: Advantages and Disadvantages, 2013
Table 5.11 Outsourcing Clinical Trial Supply and Logistics: Benefits and Weaknesses, 2013
Table 6.1 Top Ten Prescription Drugs: Biologics Share, 2012 and 2018
Table 6.2 Leading Providers of RFID Tags for the Pharmaceutical Market, 2013
Table 7.1 AmerisourceBergen: Other Service Revenue ($bn) by Company, 2012
Table 7.2 DHL Supply Chain: Revenue ($bn) by Sector, 2012
Table 7.3 Marken: Revenue ($bn), 2008-2012
Table 7.4 Catalent: Development and Clinical Services Facilities, 2013
Table 7.5 Catalent Development and Clinical Services: Revenue ($bn), 2010-2013
Table 7.6 Patheon Pharmaceutical Development Services: Revenue ($bn), 2009-2012
Table 7.7 Almac Group: Revenue ($bn), 2008-2011
Table 7.8 Parexel: Clinical Research Services Revenue ($bn), 2010-2013
Table 9.1 Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Sector, 2012, 2017 and 2023
Table 9.2 Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Region, 2012, 2017 and 2023

List of Figures

Figure 1.1 Sectors and Services in the Clinical Trial Supply and Logistics Market, 2013
Figure 1.2 Clinical Trials Registered by Country/Region, 2013
Figure 1.3 World Pharmaceutical Market Shares (%) by Country/Region, 2012
Figure 1.4 Trends Affecting the Clinical Trial Supply and Logistics Market, 2013-2023
Figure 2.1 RandD Outsourcing Market: Market Share (%) by Sector, 2012
Figure 2.2 Clinical Trial Supply and Logistics Market: Market Share (%) by Sector, 2012
Figure 2.3 Clinical Trial Supply and Logistics Market Forecast ($bn), 2012-2023
Figure 2.4 Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2017
Figure 2.5 Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2023
Figure 2.6 Clinical Trial Supply and Logistics: Market Drivers, 2013-2023
Figure 2.7 Clinical Trial Supply and Logistics: Market Restraints, 2013-2023
Figure 2.8 Clinical Trial Manufacturing Submarket: Sector Shares (%), 2012
Figure 2.9 Clinical Trial Manufacturing Submarket Forecast ($bn), 2012-2023
Figure 2.10 Clinical Trial Manufacturing: Submarket Drivers and Restraints, 2013-2023
Figure 2.11 Clinical Trial Packaging Submarket Forecast ($bn), 2012-2023
Figure 2.12 Clinical Trial Logistics and Distribution Submarket: Sector Shares (%), 2012
Figure 2.13 Clinical Trial Logistics and Distribution Submarket Forecast ($bn), 2012-2023
Figure 2.14 Clinical Trial Logistics and Distribution: Submarket Drivers and Restraints, 2013-2023
Figure 2.15 Clinical Trial Cold Chain Logistics Submarket Forecast ($bn), 2012-2023
Figure 2.16 Clinical Trial Supply Chain Management Submarket Forecast ($bn), 2012-2023
Figure 2.17 Clinical Trial Supply Chain Management: Submarket Drivers and Restraints, 2013-2023
Figure 3.1 Clinical Trial Supply and Logistics Market: Market Share (%) by Country/Region, 2012
Figure 3.2 Clinical Trial Supply and Logistics Market: Market Share (%) by Country/Region, 2012-2023
Figure 3.3 US Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.4 US Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.5 US Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 3.6 Western European Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.7 Western European Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 3.8 Western European Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.9 Western European Clinical Trial Supply and Logistics Submarket Shares (%) by Country, 2012
Figure 3.10 German and French Clinical Trial Supply and Logistics Submarket Forecasts ($bn), 2012-2023
Figure 3.11 UK, Italian and Spanish Clinical Trial Supply and Logistics Submarket Forecasts ($bn), 2012-2023
Figure 3.12 Japanese Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.13 Japanese Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.14 Japanese Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 3.15 Brazilian Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.16 Brazilian Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 3.17 Brazilian Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.18 Russian Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.19 Russian Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.20 Russian Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 3.21 Indian Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.22 Indian Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.23 Indian Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 3.24 Chinese Clinical Trial Supply and Logistics: Submarket Drivers and Restraints, 2013-2023
Figure 3.25 Chinese Clinical Trial Supply and Logistics Submarket Forecast ($bn), 2012-2023
Figure 3.26 Chinese Clinical Trial Supply and Logistics Market Share (%), 2012-2023
Figure 5.1 Players in the Clinical Trial Supply Chain, 2013
Figure 6.1 World Pharmaceutical Market Forecast by Drug Type, 2012 and 2018
Figure 7.1 AmerisourceBergen: Other Service Revenue Share (%) by Company, 2012
Figure 7.2 DHL Supply Chain: Revenue Share (%) by Sector, 2012
Figure 7.3 Marken: Revenue ($bn), 2008-2012
Figure 7.4 Catalent: Clinical Manufacturing Space by Region (%), 2013
Figure 7.5 Catalent Development and Clinical Services: Revenue ($bn), 2010-2013
Figure 7.6 Patheon Pharmaceutical Development Services: Revenue ($bn), 2009-2012
Figure 7.7 Almac Group: Revenue ($bn), 2008-2011
Figure 7.8 Parexel: Clinical Research Services Revenue ($bn), 2010-2013
Figure 9.1 Clinical Trial Supply and Logistics Market: Revenue ($bn) by Sector, 2012, 2017 and 2023
Figure 9.2 Clinical Trial Supply and Logistics Market: Revenue ($bn) by Region, 2012, 2017 and 2023

Companies Listed

3C Alliance
AbbVie
AbbVie Contract Pharmaceutical Manufacturing (part of AbbVie)
ACM Global Central Lab
Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]
Almac Group
AmerisourceBergen
AmerisourceBergen Consulting Services
AndersonBrecon (part of PCI)
Apax Partners
Aptuit
Association of Clinical Trials Organizations (ACTO)
Astellas Pharma
AstraZeneca
Bellwyck Packaging Solutions
BioClinica
Biogen Idec
Biotec Services International
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence (part of Boehringer Ingelheim)
Braeburn Pharmaceuticals
Bristol-Myers Squibb
BT
CAEN RFID
Cardinal Systems
Catalent (Shanghai) Clinical Trial Supplies
Catalent Pharma Solutions
Celesio
Cenduit
Central Drugs Standard Control Organization (CDSCO) [India]
China Food and Drug Administration (CFDA)
ClinStar (part of PRA International)
Comissão Nacional de Ética em Pesquisa (CONEP) [Brazil]
Consorcio de Apoyo a la Investigación Biomedica - Plataforma Española de Ensayos Clínicos (CAIBER)
COREX (part of 3C Alliance)
Covance
Cryoport
Cubist Pharmaceuticals
DHL
Drug Controller General of India (DCGI)
Eli Lilly
EPS Group
Escort Cold Chain Solutions
Escort Data Logging Systems
e-Trial Co. (part of EPS Group)
Eurodifarm (part of DHL)
European Commission
European Medicines Agency (EMA)
FedEx
Fisher BioServices (part of Thermo Fisher Scientific)
Fisher Clinical Services (part of Thermo Fisher Scientific)
Food and Drug Administration (FDA) [US]
Forest Laboratories
Frazier Healthcare
GE Healthcare
Greenbox
GSK
IATA Time and Temperature Task Force (TTTF)
IBM
ICON
IMP Logistics (part of PRA International)
Intelleflex
Intelsius
International Air Transport Association (IATA)
International Conference on Harmonisation (ICH)
International Pharmaceutical Federation (FIP)
JandJ
Komtur Pharmaceuticals
LabCorp
LCAG USA
LifeConEx (part of DHL)
Lonza
Marken
Mawdsleys
Medicines and Healthcare Products Regulatory Agency (MHRA) [UK]
Merck Serono
Ministry of Health [China]
Ministry of Health [Russia]
Ministry of Health, Labor and Welfare (MHLW) [Japan]
Mitsui and Co.
MNX
Movianto
National Institutes of Health (NIH) [US]
NextPharma
Novo Nordisk
N-SIDE
Nuvilex
Onyx Pharmaceuticals
Owens and Minor
Packaging Coordinators Inc (PCI)
Parexel International
Patheon
Perceptive Informatics (part of Parexel)
Pfizer
Pharmaceutical Quality Group (PQG)
Pieffe Group (part of UPS)
Pluristem Therapeutics
PRA International
Quintiles
Recipharm
Roche
Sanofi
SF Express
ShangPharma
The Riverside Company
TheraCom
Thermo Fisher Scientific
TNT Express
TransCelerate BioPharma
Tufts Center for the Study of Drug Development
University of Florida
UPS
US Pharmacopeial Convention (USP)
Vsoft Infoware
World Courier
World Health Organization (WHO)
Worldwide Clinical Trials
WuXi PharmaTech
Y Prime

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Global Proteomics Market

Global Proteomics Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of ...

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018

Molecular Spectroscopy Market by Technology [NMR (FT, Continuous Wave), UV-Visible (Photodiode Array, Handheld), IR (Terahertz, Benchtop), NIR (FT-NIR) Raman (SERS, TERS, FT Raman)] & by Application (Pharmaceutical, Food) - Forecast to 2018

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

Over the years, the molecular spectroscopy market, comprising instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the numbe ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.